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As a key technology of rapid and low-cost drug development, drug repositioning is 
getting more essential and popular for all pharmaceutical companies. Since drug 
repositioning means reuse of approved drugs for another purpose, their safety and method of 
production have already been confirmed. Besides biomedical experiments, computational 
methods are developed for drug repositioning. Most of them adopt network-based algorithms 
and combination of various databases including gene expression and pathway data. On the 
other hand, it is also suggested that text mining has much potential for drug repositioning. In 
biomedical text mining, biomedical named entities (e.g. genes, drugs, diseases, etc.) are 
recognized and the relations between these entities are extracted. Additionally, biomedical 
ontologies are utilized as the sources of semantic information for recognizing exactly names 
of biomedical entities. 
In this study, a text mining approach to the discovery of unknown drug-disease relation 
was tested. Starting from over 3 million PubMed abstracts related to cancer, biomedical 
named entities were first recognized and the relations among them were extracted. 
Biomedical ontologies such as PharmGKB, MeSH, DrugBank, and CTD databases were 
utilized for the sources of semantic information. Using a word embedding algorithm, senses 
of over 1.7 million words were well represented in sufficiently short feature vectors. Through 
various analysis including clustering and classification, feasibility of our approach was tested. 
Finally, our trained classification model achieved 87.6% accuracy in the prediction of drug-
disease relation in cancer treatment and succeeded in discovering novel drug-disease relations 




Chapter 1 Introduction 
This chapter aims to introduce generally about the content and distribution of our 
dissertation. 
 
Chương 2 Related works 
2.1 Drug repositioning 
As a new and effective strategy for drug discovery, drug repositioning (or drug 
repurposing, reprofiling, etc.) is attracting much interest and expectation from academic 
researchers and pharmaceutical companies [1]. Briefly saying, drug repositioning is reuse of 
existing drugs for other purposes. 
Besides biomedical experiments, computational methods are developed for drug 
repositioning. Especially, in rerent years it is also suggested that text mining has much 
potential for drug repositioning. 
2.2 Biomedical text mining 
 Text mining 
In general, text mining is the process of extracting information or discovering knowledge 
automatically from textual data or unstructured data. The process of text mining is quite 
similar to the process of data mining. Text mining is also known as an interdisciplinary area 
since it is related to various fields such as information retrieval, information extraction, 
natuaral language processing, data mining. 
 Biomedical text mining 
Biomedical text mining refers to the application of text mining to biomedical domain. 
Through biomedical text mining, useful knowledge, which is hidden in biomedical literature, 
can be extracted. 
 Information extraction (IE) 
Information extraction is the basic task for text mining. The process of information 
extraction includes two main tasks: named entity recognition (NER) and relation extraction 
(RE). 
 
Chương 3 Materials and methods 
3.1 Overview of processing pipeline 
The processing pipeline in this study is shown in Figure 1. It includes four phases: Text 
processing; Word embedding; Combination of word vectors and database information; and 





Figure 1. Overview of processing pipeline. Box colors indicate: light blue for corpus, light green for 
databases, yellow for word vectors, and pink for concatenated word vectors. (a), (b), (c), and (d) 
corresponding to four phases of processing pipeline. 
3.2 Resources and tools 
3.2.1 Biomedical databases 
 PubMed  
PubMed [2] is widely used in biomedical text mining community. It allows users to 
access to a large biomedical database including the summary information of published 
biomedical articles such as author, title, abstract, keywords, etc.  
 Medical Subject Headings (MeSH) 
MeSH is a comprehensive controlled vocabulary thesaurus of biomedical terms which 
is created and updated by the United States National Library of Medical (NLM) [3].  
 Pharmacogenomics Knowledgebase (PharmGKB) 
PharmGKB is a pharmacogenomics knowledge resource which is used to aggregate, 
curate, integrate, and disseminate information about the relationships between human 
genetic variations and corresponding drug responses [4]. 
 DrugBank 
DrugBank [5] is a pharmaceutical database which contains knowledge about drugs 
and drug targets. In DrugBank, Anatomical Therapeutic Chemical (ATC) code is used 
to classify active ingredients of drugs according to the system or organ. 
 Comparative Toxicogenomics Database (CTD) 
CTD provides useful information regarding relationships between different types of 







 Enju parser 
Enju is a tool for parsing English sentences developed at Tsujii Laboratory in Tokyo 
University. In our study, Enju is used for Part-Of-Speech (POS) tagging and 
conversion of words into base forms. 
 word2vec software for word embedding 
This software provides an effective implementation for computing vector 
representations of words. It was developed by Tomas Mikolov and his co-workers. 
3.3 Data preparation 
3.3.1 Cancer-related corpus from PubMed abstracts 
As a raw corpus, we used a subset of PubMed abstracts downloaded in October 2013, 
filtered by the keyword “cancer”. From 3,099,076 abstracts, 14,847,050 sentences were 
extracted.  
3.3.2 Parsing sentences 
Enju [7] was used for POS recognition of words and conversion into base forms. Since 
the sentences were extracted from biomedical abstracts, “-genia” option was specified. As a 
result, POS and base form are recognized for each word. 
So that word2vec can differently treat the same word with different POS categories, they 
were attached right after the base form of words (e.g. “care” -> “care(V)”). For readability, 
nouns are kept as is. To simplify the input for word2vec, we removed all words except nouns, 
adjectives, adverbs, and verbs. 
3.3.3 Named entity recognition and conversion into single words 
Biological terms typically consist of two or more words. In addition, they have many 
synonyms. Since word2vec basically treats a sentence as a sequence of words, it is needed to 
recognize biological synonyms, aggregate them into primary terms, and convert them into 
single words. In this study, primary names and synonyms of drugs, diseases, and genes were 
extracted from PharmGKB [8] and used for recognition and aggregation (genes are used only 
for showing distribution of word vectors). For each converted single words, prefixes 
indicating their semantic categories were attached for later processing. After all conversion, 
14,847,050 sentences are expanded to 45,264,480. 
3.3.4 Word embedding 
In this study, we used word2vec software, a de facto standard implementation of word 
embedding algorithm, with the following parameters by default. As a result, 1,772,186 words 
were embedded into word vectors (2,303 for drugs, 3,069 for diseases, 8,703 for genes, and 
1,758,111 for others). 
3.3.5 Combination of word vectors and database information 
For the evaluation of clustering results, ATC codes [9] and MeSH tree numbers [3] were 
attached to drug and disease names, respectively. ATC codes were extracted from DrugBank 
[5]. Due to the incompleteness of data annotation, only 1,253 drugs out of 2,303 and 2,745 
diseases out of 3,069 have such classification. 
3.3.6 Generation of the special vector for drug-disease relations 
For the evaluation of difference vectors between drugs and diseases, relations between 
drugs and diseases occurring in the corpus were extracted from CTD [6]. The figure 2 
illustrates the concatenation of drug and disease vectors to create drug-disease relation 
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vectors. If the relation is written in CTD with therapeutic evidence, it is labeled “TRUE” 
(otherwise, “FALSE”). Only the 12,462 relations with therapeutic evidences were adopted for 
obtaining trustable results. In the set of relations, the mapping from drugs to diseases is 
many-to-many. For example, “drug::gefitinib” is related to 17 different diseases, and 
“disease::lung_neoplasm” is mapped from 60 different drugs.  
 
Figure 2.  The concatenation of drug and disease word vectors to create drug-disease relation vectors. If 
the relation is written in CTD with therapeutic evidence, it is labeled “TRUE” (otherwise, “FALSE”). 
In order to conduct detailed analysis on cancer-related drugs and diseases, 12,462 
extracted drug-disease relations were further filtered so that both of drug and disease names 
in each relation are attached to an ATC code and a MeSH tree number beginning with “L” 
(Antineoplastic and immunomodulating agents) and “C04” (Neoplasms), respectively. As a 
result, 1,097 relations consist of 104 anti-cancer drugs and 107 cancer-related diseases were 
extracted for detailed analysis. 
3.4 Algorithms 
3.4.1 Checking the distribution of biomedical word vectors  
In order to check the distribution of biomedical word vectors for drugs, diseases, and 
genes, we adopted Principle component analysis (PCA) to convert 200-dimension vectors 
into 3-dimension vectors and plotted in 3D space. In this study, prcomp and plot3d functions 
included in stats and rgl packages respectively for R software were used. 
3.4.2 Clustering for drugs and diseases 
For visual evaluation of word vector quality, we performed hierarchical clustering with 
cosine distance and Ward's method [10]. Before the clustering, 2,303 drugs and 3,069 
diseases occurring in the corpus were reduced to 1,282 and 1,051, respectively, so that all of 
them also occur in CTD. In this study, we used hclust and plot functions included in stats and 
graphics packages respectively in R software for hierarchical clustering and visualizing 
clustering performance. 
3.4.3 Classification for drug-disease relations 
Support Vector Machine (SVM) was adopted for learning and predicting possible 
relations between drugs and diseases. As an implementation, ksvm function included in 
kernlab package for R software was used with default parameters. 
3.4.4 Cross-validation 
Cross-validation is a very popular method which is used to evaluate the performance of 
classification problems. In this study, we performed 100 times 10-fold cross-validation. Then, 
the accuracies were averaged. 







To solve class imbalanced problem, we applied the data level method in which 
corresponding to the number of positive examples (or correct drug-disease relations), the 
same number of negative examples (or incorrect drug-disease relations) were randomly 
selected, and used in each cross-validation. 
Chương 4 Experimental results and discussion 
4.1 Distribution of drug-disease-gene vectors 
Figure 3 illustrates the 3D plot of vectors corresponding to 2,303 drugs, 3,069 diseases, 
and 8,703 for genes. For visualization, the dimension of vector was reduced from 200 to 3 by 
PCA. In the top panel of the figure, it is shown that the distributions of word vectors in three 
categories are clearly separated. In the bottom panel, it is also shown that the frequent words 
have clear separation, whereas it is relatively difficult to discriminate the categories of rare 
words. 
 
Figure 3. Distribution of word vectors visualized through PCA and 3D plot. Top panel: blue, red, 
green colors indicate word vectors for drugs, diseases, and genes. Bottom panel: color gradation 






4.2 Cluster analysis for drug and disease vectors 
Figure 4 and 5 show the result of hierarchical clustering for drugs and diseases, 
respectively. In the right panels of them, entire pictures of clustering results for 1,282 drugs 
and 1,051 diseases are shown. In the right panel of Figure 4, it can be seen that most of the 
anti-cancer drugs are condensed in the ninth cluster from the top (left panel for more detail). 
It indicates that the word vectors for drugs well represent the characteristics of corresponding 
drugs. Also in Figure 5, we can see that the seventh cluster from the top contains a number of 
cancer-related diseases, however, also in sixth and ninth clusters. The difference between 
these results might come from the fact that diseases can be classified from different 




Figure 4. Result of hierarchical clustering on drugs. Red, green, blue, yellow colors for characters 
indicate that the drugs are classified in ATC codes as “L01:Antineoplastic Agents”, “L02:Endocrine 
Therapy”, “L03:Immunostimulants”, and “L04:Immunosuppressants”, respectively.  





Figure 5. Result of hierarchical clustering on diseases. Green, yellow, red, dodgerblue, pink, blue, 
and springgreen colors for characters indicate that the diseases are classified in MeSH tree numbers as 
“C04.182:Cysts”, “C04.445:Hamartoma”, “C04.557:Neoplasms by Histologic Type”, 
“C04.588:Neoplasms by Site”, “C04.697:Neoplastic Processes”, “C04.730:Paraneoplastic Syndromes”, 
and “C04.834:Precancerous Conditions”.  
 
4.3 Classification of unseen drug-disease relations 
           
10 
 
The result of performance evaluation is shown in Table 1. Each accuracy is an average of 
100 times 10-fold cross-validation with different subsets of negative examples. In this table, 
it was revealed that the performance of classification is affected by vector size and window 
size, and the best accuracy was 87.5%. For exploratory use of the classification model to 
discover candidate drug-disease pairs, it means sufficiently high performance.  
Table 1 Accuracy of classifying correct and incorrect drug-disease relations by SVM. 
vector size 
accuracy 
window size = 2 window size = 3 window size = 4 window size = 8 
50 0.872 0.873 0.875 0.872 
75 0.873 0.874 0.874 0.874 
100 0.874 0.874 0.874 0.876 
200 0.874 0.874 0.874 0.874 
 
Finally, we tested all combinations of 2,199 drugs not used in training and 107 cancer-
related diseases (in total, 235,293 drug-disease pairs). In case of the classification model 
trained by 11,128 samples, only 64 test samples were predicted as positive, and all the drugs 
in the sample were anti-cancer drugs (but not included in 104 anti-cancer drugs used for 
training). By controlling the degree of class imbalance in training data, it is possible to 
predict a pair of non-anti-cancer drug and cancer-related disease as positive. For example, 
using the classification model trained by 1,097 positive and 8,776 negative samples (degree 
of imbalance is 1:8), 10 times training and test by 235,293 drug-disease pairs discovered the 
following candidate drugs for repositioning to cancer treatment, where the numbers indicate 
how many times they were discovered in 10 times training and test.  
drug::urokinase(10), drug::photodynamic_therapy(10),  drug::oxygen(10),  drug::nonoxynol-9(10),   
drug::nitroglycerin(10),  drug::nitrogen(10),  drug::l-phenylalanine(10),  drug::l-methionine(10),   
drug::l-glutamine(10),  drug::l-cysteine(10),  drug::glutathione(10),  drug::glucose(10),   
drug::epoxide(10),  drug::enzyme(10),  drug::collagenase(10),  drug::bisphosphonate(10),   
drug::amino_acid(10),  drug::amide(10),  drug::clarithromycin(9),  drug::vitamin(8),  drug::l-proline(7),   
drug::vitamin_e(6),  drug::xanthophyll(4),  drug::phospholipid(4),  drug::palifermin(4),  drug::ether(4),   
drug::ethacrynic_acid(4),  drug::denosumab(4),  drug::egfr_inhibitor(2),  drug::pyruvic_acid(1). 
Besides too general names like “drug::enzyme” and “drug::amide”, it is notable that the 
above list includes approved anti-cancer drugs (e.g. “drug::denosumab”), anti-cancer drugs 
under investigation (e.g. “drug::clarithromycin”, “drug::bisphosphonate”, and 
“drug::xanthophyll”), and drugs potentially promote cancer (e.g. “drug::urokinase” and 
“drug::collagenase”). Especially, it should be emphasized that repositioning of clarithromycin 
to anti-cancer agent has been reported in 2015 [11], despite the fact that the corpus was 
downloaded in 2013. Though further screening based on expert’s knowledge is necessary, 
this result demonstrate that the classification of concatenated word vector is a promising 
approach to in-silico screening of drug-disease relations for drug repositioning. 
 
Chương 5 Conclusion and future works 
5.1 Dissertation summary 
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In this study, we applied text mining techniques to drug repositioning in order to (i) 
check the distribution of biomedical words; (ii) analyze clustering of anti-cancer drug vectors 
and cancer-related disease vectors; (iii) find unseen drug-disease relations by classification. 
From experimental results, it was revealed that word embedding is effective for 
representing sense of all words in large amount of cancer-related PubMed abstracts. 
Furthermore, concatenation of word vectors of drugs and diseases well represents their 
relations and could be used for finding candidate drugs for repositioning by classification. 
5.2 Future works 
For better performance of classification, various feature selection and over-sampling 
algorithms [12] will be tested in the future work. Additionally, we will apply this method to 
other kinds of diseases as well as new kinds of biomedical relations such as gene-disease 
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